Karim Parastouei

Dr. Karim Parastouei

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SHSaeid Hosseini
Saeid Hosseini
KPKarim Parastouei
Karim Parastouei
FKFaramarz Khodaiyan
Faramarz Khodaiyan

1 December 2019 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
AHAmir Hadi
Amir Hadi
MSMojtaba Sepandi
Mojtaba Sepandi
WMWolfgang Marx
Wolfgang Marx
SMSajjad Moradi
Sajjad Moradi
KPKarim Parastouei
Karim Parastouei

3 October 2022 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
ASAbbas Ali Sangouni
Abbas Ali Sangouni
MTMaryam Taghdir
Maryam Taghdir
JMJavad Mirahmadi
Javad Mirahmadi
MSMojtaba Sepandi
Mojtaba Sepandi
KPKarim Parastouei
Karim Parastouei
Background: Metabolic syndrome (MetS) as a cluster of conditions including hyperlipidemia, hypertension, hyperglycemia, insulin resistance, and abdominal obesity is linked to cardiovascular diseases and type 2 diabetes. Evidence suggested that intake of curcumin and coenzyme Q10 may have therapeutic effects in the management of MetS. Aims: We investigated the effects of curcumin and/or coenzyme Q10 supplementation on metabolic syndrome components including systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), triglyceride (TG), high density lipoprotein-cholesterol (HDL-c) and fasting plasma glucose (FPG) as primary outcomes, and total cholesterol (TC), low density lipoprotein-cholesterol (LDL-c) and body mass index (BMI) as secondary outcomes in subjects with MetS. Methods: In this 2 × 2 factorial, randomized, double-blinded, placebo-controlled study, 88 subjects with MetS were randomly assigned into four groups including curcumin plus placebo (CP), or coenzyme Q10 plus placebo (QP), or curcumin plus coenzyme Q10 (CQ), or double placebo (DP) for 12 weeks. Results: The CP group compared with the three other groups showed a significant reduction in HDL-c (P = 0.001), TG (P < 0.001), TC (P < 0.001), and LDL-c (P < 0.001). No significant differences were seen between the four groups in terms of SBP, DBP, FPG, WC, BMI and weight. Conclusion: Curcumin improved dyslipidemia, but had no effect on body composition, hypertension and glycemic control. Furthermore, coenzyme Q10 as well as the combination of curcumin and coenzyme Q10 showed no therapeutic effects in subjects with MetS. The trial was registered on 09/21/2018 at the Iranian clinical trials website (IRCT20180201038585N2), URL: https://www.irct.ir/trial/32518.

1 December 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
FKFaramarz Khodaiyan
Faramarz Khodaiyan
KPKarim Parastouei
Karim Parastouei

1 November 2019 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MBMustafa Badely
Mustafa Badely
MSMojtaba Sepandi
Mojtaba Sepandi
MSMohammad Samadi
Mohammad Samadi
KPKarim Parastouei
Karim Parastouei
MTMaryam Taghdir
Maryam Taghdir

10 October 2023 in Preventive Medicine Reports
Verified
Journal Article
Open access
NRNima Radkhah
Nima Radkhah
ARAhmadreza Rasouli
Ahmadreza Rasouli
AMAmin Majnouni
Amin Majnouni
EEEslam Eskandari
Eslam Eskandari
KPKarim Parastouei
Karim Parastouei
Evidence suggests that adopting a healthy diet, such as the Mediterranean Diet (MD), can positively affect mental health. To further explore this, a study was conducted to determine the impact of MD instruction over 12 weeks on depression, anxiety, stress, and anthropometric indices. The study is a randomized, double-blind, controlled clinical trial with sixty participants who reported stress, anxiety, and depression conducted in Tabriz, Iran (2022–2023). They were randomly assigned to either the intervention group (n = 30), which received MD instruction, or the control group (n = 30), which received standard healthy nutrition education. Both groups were asked to follow their respective nutrition education plans for 12 weeks. After 12 weeks, depression, anxiety, and stress levels were measured using the DASS-21 questionnaire, and anthropometric indices were assessed. Initially, the unadjusted DASS-21 scores for depression, anxiety, and stress did not show significant differences between the two groups. However, after adjusting for baseline variables (model 2), all scores decreased significantly (the P-value for all scores was < 0.001). There was no significant difference in weight and BMI between the intervention and control groups. However, after adjusting the results based on baseline values (Model 2) and adherence to the program (Model 3), weight and BMI were significantly reduced in the MD group (P-values for both cases and both models were < 0.001). Overall, despite some significant findings, the results were not noticeable from a clinical perspective. The study provides some indications that following the Mediterranean diet may lead to improvements in weight and mental well-being.